Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and ...

But a new study suggests one more factor deserves serious attention—chronological age. Researchers from University Hospitals ...

We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer ...

The two drugs—apalutamide and finasteride—were tested in lab experiments using mice and human cells affected by AML. The ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about managing side effects following prostate cancer treatment. While treatment ...

An estimated one in eight men will be diagnosed with prostate cancer in their lifetime, often after 65. And as terrifying as that number is, a diagnosis isn’t always quite what it seems. Today, the ...

Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute ...

CHARLOTTE, NC / ACCESSWIRE / January 14, 2020 / HIFU Prostate Services, LLC, the leading provider of HIFU technology to physician practices in the United States, has partnered with Urology Austin, the ...

SEATTLE, WA / ACCESSWIRE / December 4, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...